BioMarin receives French FDI clearance for Amicus merger; closing expected April 27, 2026

BIOMARIN PHARMACEUTICAL INC

French Ministry of Economics and Finance granted FDI clearance for merger with Amicus on April 23, 2026.
Receipt of clearance satisfies final condition to the merger other than closing conditions.
Merger expected to close on April 27, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.